Can Emerging Therapies Resolve Unmet Needs With Current Treatment in Early-Stage Alzheimer Disease?

Can Emerging Therapies Resolve Unmet Needs With Current Treatment in Early-Stage Alzheimer Disease? is organized by CME Institute of Physicians Postgraduate Press, Inc. (PPP)

Activity opens: 05/13/2021
Activity expires: 05/31/2023

Description:
How do investigational drugs for Alzheimer's disease differ from those currently prescribed to patients? Dr Burke shares her insights.

Learning Objectives:
Consider how emerging agents focused on reducing progression would resolve unmet treatment needs in patients living with early-stage Alzheimer disease.

Additional details will be posted as soon as information is available.